Important: Compounded medications are not FDA-approved finished drug products. They are not equivalent to branded drugs like Wegovy, Ozempic, or Zepbound. Compounded GLP-1 medications differ in formulation, regulation, and approval status. Always consult a licensed healthcare provider.
The FDA has proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulk compounding list, citing no identified clinical need. Public comments were extended through July 30, 2026. If finalized, this could affect the availability, pricing, and continuity of some compounded GLP-1 programs. We will update this page as the regulatory situation develops.
Mochi Pricing Note: Mochi’s listed membership fee covers clinical access only. Compounded GLP-1 medication is an additional cost billed separately. Total monthly cost = membership + medication.
Hims GLP-1 Note: Hims has offered compounded semaglutide alongside FDA-approved medications like the Wegovy pill and pen; which formulations (oral or injectable) are available, and their pricing, change frequently, confirm current offerings with Hims directly. Compounded medications are prepared by partner pharmacies and are not FDA-approved finished drug products.
Cash-Pay Compounded Programs, Verified Prices
These are the cash-pay programs we track with published entry pricing, ranked by verified monthly cost for compounded semaglutide. Every figure below was read from the provider’s live site on the date shown; promotional rates are flagged, because they can change or expire.
| Program | Compounded semaglutide, entry price | What’s included | Verified |
|---|---|---|---|
| Embody GLP-1 | $149/mo promotional rate (listed as “was $299”) | Medication + prescription + telemed visits; same price every dose; not available in MS or LA | Jul 14, 2026 |
| Sprout Health | From $149/mo (starting dose) | Medication + clinician support; higher doses cost more | Jul 3, 2026 |
| TMates | $158/mo (with advertised $100-off promotion) | Medication + prescription + telemed visits; no membership fee | Jul 9, 2026 |
| Mochi Health | $79/mo membership + $99/mo medication (~$178 combined, all doses) | Membership covers clinical care; medication billed separately (see note above) | Jul 3, 2026 |
| Henry Meds | From $179/mo (varies by plan and dose) | Medication + provider visits + supplies + ongoing care | Jul 9, 2026 |
| Direct Meds | From $249/mo (sublingual) to $297/mo (injection) | All-inclusive; not available in LA | 2026-07-25 |
| ShedRx | Injections and lozenges from $199/mo; liquid drops from $229/mo | Program pricing by format; not available in LA | 2026-07-21 |
| Care Bare Rx | From $199/mo | Program pricing; not available in LA | May 7, 2026, oldest figure here; confirm before enrolling |
Eden also markets cash-pay compounded semaglutide from about $129 for the first month on some plans, first-month promotional pricing, so confirm the ongoing rate. For the always-current ranking across every program we track, see the GLP-1 Price Index.
Your Main Cash-Pay Options
There are basically three routes: compounded medication through a telehealth platform, brand-name medication through a telehealth platform, and retail brand-name pricing at the pharmacy.
The third route is usually the most painful on price. Ro’s own pricing page shows Ozempic at roughly $900 to $1,100/month without insurance. That is why uninsured shoppers usually end up comparing the compounded programs in the table above instead.
If You Want Brand-Name Medication Instead
A few programs are built around brand-name Wegovy or Zepbound rather than the cheapest cash price. Ro pairs a membership ($149/mo, less on annual prepay; verified Jul 3, 2026) with separately billed brand-name medication and helps run insurance prior authorization. Calibrate is a $199/mo coaching membership designed around insurance-covered medication with copays of $25/month or less (verified Jul 3, 2026), which makes it an insurance-path program, not a cash-pay bargain. Hims has offered both compounded and brand-name formulations; see the note above. These paths make the most sense when insurance coverage is realistic, without it, expect brand-name costs several times the compounded table above (compare the $900–$1,100/month Ozempic figure to the $149–$299 range in the table).
The Real Tradeoff
Without insurance, you are often choosing between lower cost with compounded medication and higher confidence with brand-name medication. There is no universal right answer, see our guide on compounded vs brand-name GLP-1s for the full breakdown.
FAQ
Is insurance required for GLP-1 telehealth?
No. Embody, TMates, and Henry Meds all state plainly that insurance is not required (verified on their sites, July 2026), and cash-pay access is the core model at Eden and Mochi as well.
What is the cheapest way to get GLP-1s without insurance?
Usually a compounded-GLP-1 program, not a brand-name retail path. At verified current rates, the lowest published all-in entry prices here are tied at $149/mo, Embody’s $149/mo promotional rate (“was $299”; verified Jul 14, 2026) and Sprout Health’s $149/mo, with TMates at $158/mo close behind. A few programs RY tracks go lower, Strut Health’s sublingual from $99/mo, bmiMD from $99/mo on a 12-month plan, and Trimi at $99/mo billed annually, each with a format or commitment tradeoff. Promotional prices change, confirm the rate and what your dose costs before enrolling.
Can I still get FDA-approved brand-name GLP-1s without insurance?
Yes, but the monthly cost can be much higher, as a reference point, Ro’s own pricing page shows Ozempic at roughly $900 to $1,100/month without insurance.
Can any program guarantee me a prescription?
No. In every legitimate program, a licensed clinician reviews your health history and prescribes only when treatment is clinically appropriate. Treat any guaranteed-prescription claim as a red flag.
Insurance coverage for GLP-1 medications varies widely by plan, provider, and medication type. Coverage is not guaranteed.
Prices change frequently, always confirm current rates on each provider’s website before purchasing.
RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Last reviewed July 16, 2026.
